BraiN20® Medical Device in Suspected Acute Stroke Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT06421337

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Alicia Martínez Piñeiro (from the registry)
Registry
  • NCT NCT06421337
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06421337. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-15 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BraiN20® Medical Device in Suspected Acute Stroke Patients
Acronym
PROMISE-GLOB
Condition
Acute Stroke
Intervention (Device)
BraiN20(R)
Lead sponsor
Alicia Martínez Piñeiro (class: other)

Record details

Record id
cardio:ct-nct06421337
Content hash
cc6e807de0a1ba26e91f5ae97adcde71fb3ae6e8466259d522a36bf67db39a44